Absorption and Bioavailability of Oral Transmucosal Fentanyl Citrate
James B. Streisand, Theodore H. Stanley, Michael A. Ashburn(University of Pennsylvania), Leon Le Maire(Visiting Nurse Association), Brian Hague(University of Utah), John R. Varvel(St. Elizabeth Healthcare), Donald R. Stanski(United States Department of Veterans Affairs), Stephen Tarver(University of Utah)
Cited by 248
Related Papers
Frequent Hypoxemia and Apnea after Sedation with Midazolam and Fentanyl
|Anesthesiology|1990|652
Adverse events associated with postoperative opioid analgesia: A systematic review
|Journal of Pain|2002|505
Management of chronic pain
|The Lancet|1999|368
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
|Kidney International|2011|258
Cost of Opioid-Related Adverse Drug Events in Surgical Patients
|Journal of Pain and Symptom Management|2003|226